● Recruiting

Hydroxychloroquine in Mild Graves' Orbitopathy

Condition: Graves Ophthalmopathy · Sponsor: National Taiwan University Hospital

PhasePhase 4

Planned participants108

Who can joinAll sexes, 18 Years to 75 Years

Healthy volunteersNo

About this study

This study is aimed to investigate the effect of hydroxychloroquine in patients with mild Graves' orbitopathy (GO).

This description comes directly from the study's public registry record.

Talk to the study team

Shyang-Rong Shih · +886-2-23123456 · srshih@ntu.edu.tw

Hung-Yuan Li · +886-2-23123456 · larsli@ntuh.gov.tw

Always discuss trial participation with your own doctor first.

Locations (2)

National Taiwan University Hospital, Hsin-Chu branch	Hsinchu, Taiwan	Recruiting
National Taiwan University Hospital	Taipei, Taiwan	Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05126147